• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

    3.690 -0.250 (-6.35%)
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 15, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,760,200
    Open 3.970
    Bid (Size) 3.650 (600)
    Ask (Size) 3.750 (300)
    Prev. Close 3.940
    Today's Range 3.645 - 4.020
    52wk Range 1.665 - 6.050
    Shares Outstanding 112,280,375
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Maravai LifeSciences Announces November 2025 Investor Conference Schedule
    From Maravai LifeSciences, Inc.
    Via Business Wire
    News headline image
    Maravai LifeSciences (MRVI) Stock Plummets After Q3 2025 Revenue Miss and Weak Guidance ↗
    Maravai LifeSciences (MRVI) stock fell after Q3 2025 revenue missed estimates. The company reported a net loss and provided full-year guidance below analyst expectations. 
    Via Chartmill

    Performance

    YTD
    +8.5%
    +8.5%
    1 Month
    +2.8%
    +2.8%
    3 Month
    +5.7%
    +5.7%
    6 Month
    +47.0%
    +47.0%
    1 Year
    -19.1%
    -19.1%

    More News

    Read More
    News headline image
    Maravai LifeSciences Reports Third Quarter 2025 Financial Results
    From Maravai LifeSciences Holdings, Inc.
    Via Business Wire
    News headline image
    Earnings Scheduled For November 6, 2025 ↗
    Via Benzinga
    News headline image
    MARAVAI INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Maravai Long-Term Stockholders
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    What to Expect from Maravai LifeSciences's Earnings ↗
    Via Benzinga
    News headline image
    Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025
    From Maravai LifeSciences, Inc.
    Via Business Wire
    News headline image
    MARAVAI (MRVI) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Maravai LifeSciences Reports Second Quarter 2025 Financial Results
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    News headline image
    Beyond the Headlines: A Look at Today's Key Corporate Earnings Reports
    Via MarketMinute
    Topics Economy Stocks
    News headline image
    Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    News headline image
    Earnings Scheduled For August 11, 2025 ↗
    Via Benzinga
    News headline image
    MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI
    From Kahn Swick & Foti, LLC
    Via Business Wire
    News headline image
    MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI
    From Kahn Swick & Foti, LLC
    Via Business Wire
    News headline image
    Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    News headline image
    Maravai ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    News headline image
    TriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping Technology
    From TriLink BioTechnologies
    Via Business Wire
    News headline image
    CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    News headline image
    Maravai LifeSciencesReleases 2024 Sustainability Report
    From Maravai LifeSciences Holdings LLC
    Via GlobeNewswire
    News headline image
    TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions
    From TriLink BioTechnologies
    Via Business Wire

    Frequently Asked Questions

    Is Maravai LifeSciences Holdings, Inc. - Class A common stock publicly traded?
    Yes, Maravai LifeSciences Holdings, Inc. - Class A common stock is publicly traded.
    What exchange does Maravai LifeSciences Holdings, Inc. - Class A common stock trade on?
    Maravai LifeSciences Holdings, Inc. - Class A common stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Maravai LifeSciences Holdings, Inc. - Class A common stock?
    The ticker symbol for Maravai LifeSciences Holdings, Inc. - Class A common stock is MRVI on the Nasdaq Stock Market
    What is the current price of Maravai LifeSciences Holdings, Inc. - Class A common stock?
    The current price of Maravai LifeSciences Holdings, Inc. - Class A common stock is 3.690
    When was Maravai LifeSciences Holdings, Inc. - Class A common stock last traded?
    The last trade of Maravai LifeSciences Holdings, Inc. - Class A common stock was at 01/15/26 04:00 PM ET
    What is the market capitalization of Maravai LifeSciences Holdings, Inc. - Class A common stock?
    The market capitalization of Maravai LifeSciences Holdings, Inc. - Class A common stock is 414.31M
    How many shares of Maravai LifeSciences Holdings, Inc. - Class A common stock are outstanding?
    Maravai LifeSciences Holdings, Inc. - Class A common stock has 414M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.